Selegiline orally disintegrating tablet in the treatment of Parkinson’’s disease

By Clarke Anthony   Jankovic Joseph  

Therapy, Vol. 3, Iss. 3, 2006-05 ,pp. : 349-356

Future Medicine

Access to resources Recommend Favorite

Levodopa-related wearing-off in Parkinson's disease: identification and management

By Pahwa Rajesh   Lyons Kelly E.  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 841-849

Informa Healthcare

Access to resources Recommend Favorite

Sublingual fentanyl orally disintegrating tablet in daily practice: efficacy, safety and tolerability in patients with breakthrough cancer pain

By ÜÜberall Michael A.   Müüller-Schwefe Gerhard H.H.  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1385-1394

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off

By Findley Leslie J   Lees Andrew   Apajasalo Marjo   Pitkänen Anna   Turunen Heidi  

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 1005-1014

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological compliance and acceptability of lansoprazole orally disintegrating tablets in primary care

By Márquez-Contreras E.   Gil V.   López J.   Plazas M. J.   Heras J.   Galván J.   Porcel J.  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 569-576

Informa Healthcare

Access to resources Recommend Favorite